BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Discovery of New Targets and Pathways for T-ALL Therapy |
Dana-Farber Cancer Institute / Thomas Look |
Bridge Grants |
2012 |
Massachusetts |
Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma |
Dana-Farber Cancer Institute / Kimberly Stegmaier, MD |
Bridge Grants |
2012 |
Massachusetts |
Searching for genetic vulnerabilities in osteosarcoma through genome-wide RNAi screening |
Dana-Farber Cancer Institute / Stuart Orkin, MD |
Innovation Grants |
2012 |
Massachusetts |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |
Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute / Julia Etchin |
Young Investigator Grants |
2012 |
Massachusetts |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
Dana-Farber/Children’s Hospital Cancer Center Developmental Therapeutics Center of Excellence |
Dana-Farber Cancer Institute / Steven DuBois, MD & Wendy London, PhD |
Center of Excellence Grants |
2012 |
Massachusetts |
Mechanisms of PPM1D in Medulloblastoma Tumorigenesis and Invasion |
Emory University / Robert Craig Castellino, MD |
Bridge Grants |
2012 |
Georgia |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |